机械通气COVID-19患者呼吸系统顺应性的评估
该研究为国际COVID-19重症监护联盟的回顾性观察性队列,纳入22个国家745例接受机械通气的COVID-19患者,描述呼吸系统静态顺应性(CRS)及其与通气管理和结局的关系。CRS在插管48小时内可获取者649例,与症状至机械通气时间(p=0.417)及PaO2/FiO2(p=0.100)无关;女性CRS低于男性(差值95%CI -11.8至-7.4 mL/cmH2O,p<0.001)。CRS与驱动压显著相关(CRS每增加1 mL/cmH2O,驱动压估计降低0.31 cmH2O/L,95%CI -0.48至-0.14,p<0.001)。28天ICU死亡竞争风险为35.6%(SE 1.7),CRS每增加10 mL/cmH2O仅与28天内转出ICU相关(HR 1.14,95%CI 1.02-1.28,p=0.018)。
要点
- 机械通气48小时内CRS与28天ICU死亡预测价值有限,仅与28天内转出ICU相关(HR 1.14/10 mL/cmH2O,95%CI 1.02-1.28,p=0.018)。
- CRS与驱动压显著相关:CRS每增加1 mL/cmH2O,驱动压估计降低0.31 cmH2O/L(95%CI -0.48至-0.14,p<0.001)。
- 女性CRS低于男性(差值95%CI -11.8至-7.4 mL/cmH2O,p<0.001),尽管女性BMI更高,但BMI与CRS关联仅为边缘性(p=0.139)。
- 插管48小时内CRS与症状至机械通气时间(p=0.417)及PaO2/FiO2(p=0.100)均无关。
- 28天ICU死亡竞争风险为35.6%(SE 1.7)。
适用人群与场景
- 2020年1月14日至12月31日入住ICU并接受机械通气、且在机械通气前7天内至少有一次CRS值的COVID-19患者,来自22个国家。
- 中位年龄62岁(IQR 52-71),男性占68%,欧洲/北美和南美占88%。
诊断标准与关键阈值
- CRS计算公式:潮气量/[气道平台压-呼气末正压(PEEP)]。
研究设计与关键结果
- 研究类型:回顾性观察性队列研究,国际COVID-19重症监护联盟快速数据收集,纳入22个国家745例患者。
- 插管48小时内CRS可获取者649例,CRS与症状至机械通气时间无关(p=0.417),与PaO2/FiO2无关(p=0.100)。
- 女性CRS低于男性(差值95%CI -11.8至-7.4 mL/cmH2O,p<0.001);女性BMI更高,但BMI与CRS关联为边缘性(p=0.139)。
- 通气管理随CRS范围变化,CRS与驱动压显著相关(CRS每增加1 mL/cmH2O,驱动压估计降低0.31 cmH2O/L,95%CI -0.48至-0.14,p<0.001)。
- 28天ICU死亡竞争风险为35.6%(SE 1.7);Cox比例风险分析显示CRS每增加10 mL/cmH2O仅与28天内转出ICU相关(HR 1.14,95%CI 1.02-1.28,p=0.018)。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,机械通气开始48小时内测得的CRS对28天死亡的预测价值有限,但与28天内转出ICU相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Heterogeneous respiratory system static compliance (CRS) values and levels of hypoxemia in patients with novel coronavirus disease (COVID-19) requiring mechanical ventilation have been reported in previous small-case series or studies conducted at a national level.
METHODS: We designed a retrospective observational cohort study with rapid data gathering from the international COVID-19 Critical Care Consortium study to comprehensively describe CRS-calculated as: tidal volume/[airway plateau pressure-positive end-expiratory pressure (PEEP)]-and its association with ventilatory management and outcomes of COVID-19 patients on mechanical ventilation (MV), admitted to intensive care units (ICU) worldwide.
RESULTS: We studied 745 patients from 22 countries, who required admission to the ICU and MV from January 14 to December 31, 2020, and presented at least one value of CRS within the first seven days of MV. Median (IQR) age was 62 (52-71), patients were predominantly males (68%) and from Europe/North and South America (88%). CRS, within 48 h from endotracheal intubation, was available in 649 patients and was neither associated with the duration from onset of symptoms to commencement of MV (p = 0.417) nor with PaO2/FiO2 (p = 0.100). Females presented lower CRS than males (95% CI of CRS difference between females-males: - 11.8 to - 7.4 mL/cmH2O p < 0.001), and although females presented higher body mass index (BMI), association of BMI with CRS was marginal (p = 0.139). Ventilatory management varied across CRS range, resulting in a significant association between CRS and driving pressure (estimated decrease - 0.31 cmH2O/L per mL/cmH20 of CRS, 95% CI - 0.48 to - 0.14, p < 0.001). Overall, 28-day ICU mortality, accounting for the competing risk of being discharged within the period, was 35.6% (SE 1.7). Cox proportional hazard analysis demonstrated that CRS (+ 10 mL/cm H2O) was only associated with being discharge from the ICU within 28 days (HR 1.14, 95% CI 1.02-1.28, p = 0.018).
CONCLUSIONS: This multicentre report provides a comprehensive account of CRS in COVID-19 patients on MV. CRS measured within 48 h from commencement of MV has marginal predictive value for 28-day mortality, but was associated with being discharged from ICU within the same period. Trial documentation: Available at https://www.covid-critical.com/study .
TRIAL REGISTRATION: ACTRN12620000421932.
参考来源
- Li Bassi G, Suen JY, Dalton HJ, et al. An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients. Crit Care. 2021. PMID: 34108029. doi:10.1186/s13054-021-03518-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。